NuVasive Bilan de santé
Santé financière contrôle des critères 3/6
NuVasive possède un total de capitaux propres de $892.5M et une dette totale de $795.5M, ce qui porte son ratio d'endettement à 89.1%. Son actif total et son passif total sont $2.1B et de $1.2B. L'EBIT de NuVasive est $82.6M ce qui fait que son ratio de couverture des intérêts 6.1. Elle dispose de liquidités et de placements à court terme de $80.7M.
Informations clés
89.1%
Ratio d'endettement
US$795.54m
Dette
| Ratio de couverture des intérêts | 6.1x |
| Argent liquide | US$80.72m |
| Fonds propres | US$892.54m |
| Total du passif | US$1.20b |
| Total des actifs | US$2.09b |
Mises à jour récentes de la santé financière
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Analyse de la situation financière
Passif à court terme: Les actifs à court terme de NUVA ( $728.3M ) dépassent ses passifs à court terme ( $582.6M ).
Passif à long terme: Les actifs à court terme de NUVA ( $728.3M ) dépassent ses passifs à long terme ( $614.4M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de NUVA ( 80.1% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de NUVA est passé de 80.6% à 89.1% au cours des 5 dernières années.
Couverture de la dette: La dette de NUVA n'est pas bien couverte par le flux de trésorerie opérationnel ( 17.5% ).
Couverture des intérêts: Les paiements d'intérêts de NUVA sur sa dette sont bien couverts par l'EBIT ( 6.1 x couverture).